iPSC-Derived Cell Therapies Summit to Feature Discussion on Trailblazing Therapies for Immuno-Oncology-Panelists Include Exacis Biotherapeutics CEO

By |2022-10-12T03:39:27+00:00October 12th, 2022|

Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will participate in an industry leader fireside chat focused on “Taking a Look at the Current Learnings from iPSC-Derived Cell Therapies and Determining Future Outlook and Developments” at the 2nd iPSC-Derived Cell Therapies Summit.

Go to Top